Sep 18, 2019
About thirty years ago SSRIs came on the market and they were immediately branded as being a “miracle cure for depression.” It took a few years before they became mainstream.
Ketamine is something of a tranquilizer/hallucinogen. It has been traditionally used in anesthesia. It was only in March 2019 when the FDA approved ketamine as an entirely new treatment for depression. “This is a game-changer,” says John Krystal, MD, and chief psychiatrist at Yale Medicine and one of the chief pioneers of ketamine research in the country.